TCR2 Trademark

Trademark Overview

On Thursday, June 11, 2015, a trademark application was filed for TCR2 with the United States Patent and Trademark Office. The USPTO has given the TCR2 trademark a serial number of 86660163. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2019. This trademark is owned by TCR2, Inc.. The TCR2 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases

Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics
tcr2

General Information

Serial Number86660163
Word MarkTCR2
Filing DateThursday, June 11, 2015
Status700 - REGISTERED
Status DateTuesday, November 5, 2019
Registration Number5903400
Registration DateTuesday, November 5, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2016

Trademark Statements

Goods and ServicesBiotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases
Goods and ServicesScientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics
Pseudo MarkTCR TWO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 16, 2015
Primary Code005
First Use Anywhere DateWednesday, July 24, 2019
First Use In Commerce DateWednesday, July 24, 2019
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 16, 2015
Primary Code042
First Use Anywhere DateWednesday, November 30, 2016
First Use In Commerce DateWednesday, November 30, 2016

Trademark Owner History

Party NameTCR2 THERAPEUTICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameTCR2 THERAPEUTICS INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameTCR2, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameTCR2, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, November 5, 2019REGISTERED-PRINCIPAL REGISTER
Friday, October 4, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 3, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 9, 2019ASSIGNED TO LIE
Wednesday, September 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 3, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 3, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 29, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 29, 2019NON-FINAL ACTION E-MAILED
Thursday, August 29, 2019SU - NON-FINAL ACTION - WRITTEN
Tuesday, August 6, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 1, 2019USE AMENDMENT FILED
Thursday, August 1, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, February 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 5, 2019EXTENSION 5 GRANTED
Monday, January 28, 2019EXTENSION 5 FILED
Monday, February 4, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 30, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, January 28, 2019TEAS EXTENSION RECEIVED
Wednesday, July 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 23, 2018EXTENSION 4 GRANTED
Monday, July 23, 2018EXTENSION 4 FILED
Monday, July 23, 2018TEAS EXTENSION RECEIVED
Thursday, February 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 30, 2018EXTENSION 3 GRANTED
Tuesday, January 30, 2018EXTENSION 3 FILED
Tuesday, January 30, 2018TEAS EXTENSION RECEIVED
Wednesday, December 6, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 6, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 19, 2017EXTENSION 2 GRANTED
Wednesday, July 19, 2017EXTENSION 2 FILED
Wednesday, July 19, 2017TEAS EXTENSION RECEIVED
Wednesday, February 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2017EXTENSION 1 GRANTED
Monday, January 30, 2017EXTENSION 1 FILED
Monday, January 30, 2017TEAS EXTENSION RECEIVED
Tuesday, September 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 6, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 28, 2016EXAMINER'S AMENDMENT ENTERED
Saturday, May 28, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, May 28, 2016EXAMINERS AMENDMENT E-MAILED
Saturday, May 28, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 3, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 3, 2016NON-FINAL ACTION E-MAILED
Tuesday, May 3, 2016NON-FINAL ACTION WRITTEN
Thursday, April 7, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 21, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 7, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 7, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 31, 2016ASSIGNED TO LIE
Monday, March 21, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 21, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 23, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2015NON-FINAL ACTION WRITTEN
Monday, September 21, 2015ASSIGNED TO EXAMINER
Wednesday, June 17, 2015NOTICE OF PSEUDO MARK E-MAILED
Tuesday, June 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 15, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics based pharmaceutical namely research treatment cancer polypeptide biotherapeutics biotechnology